1. Estimating cumulative pathway effects on risk for age-related macular degeneration using mixed linear models. Hall JB, Cooke Bailey JN, Hoffman JD, Pericak-Vance MA, Scott WK, Kovach JL, Schwartz SG, Agarwal A, Brantley MA, Haines JL, Bush WS (2015) BMC Bioinformatics : 329
    › Primary publication · 26467978 (PubMed) · PMC4606903 (PubMed Central)
  2. Mitochondrial haplogroups are associated with severity of diabetic retinopathy. Estopinal CB, Chocron IM, Parks MB, Wade EA, Roberson RM, Burgess LG, Brantley MA, Samuels DC (2014) Invest Ophthalmol Vis Sci 55(9): 5589-95
    › Primary publication · 25118268 (PubMed) · PMC4160073 (PubMed Central)
  3. Elevated transforming growth factor β1 in plasma of primary open-angle glaucoma patients. Kuchtey J, Kunkel J, Burgess LG, Parks MB, Brantley MA, Kuchtey RW (2014) Invest Ophthalmol Vis Sci 55(8): 5291-7
    › Primary publication · 25061114 (PubMed) · PMC4142830 (PubMed Central)
  4. Metabolome-wide association study of neovascular age-related macular degeneration. Osborn MP, Park Y, Parks MB, Burgess LG, Uppal K, Lee K, Jones DP, Brantley MA (2013) PLoS One 8(8): e72737
    › Primary publication · 24015273 (PubMed) · PMC3754980 (PubMed Central)
  5. Genetics and diabetic retinopathy. Schwartz SG, Brantley MA, Flynn HW (2013) Curr Diabetes Rev 9(1): 86-92
    › Primary publication · 22950970 (PubMed)
  6. The short-term effects of antioxidant and zinc supplements on oxidative stress biomarker levels in plasma: a pilot investigation. Brantley MA, Osborn MP, Sanders BJ, Rezaei KA, Lu P, Li C, Milne GL, Cai J, Sternberg P (2012) Am J Ophthalmol 153(6): 1104-9.e2
    › Primary publication · 22381365 (PubMed) · PMC3358482 (PubMed Central)
  7. Plasma biomarkers of oxidative stress and genetic variants in age-related macular degeneration. Brantley MA, Osborn MP, Sanders BJ, Rezaei KA, Lu P, Li C, Milne GL, Cai J, Sternberg P (2012) Am J Ophthalmol 153(3): 460-467.e1
    › Primary publication · 22035603 (PubMed) · PMC3288635 (PubMed Central)
  8. Heritability and genome-wide association study to assess genetic differences between advanced age-related macular degeneration subtypes. Sobrin L, Ripke S, Yu Y, Fagerness J, Bhangale TR, Tan PL, Souied EH, Buitendijk GH, Merriam JE, Richardson AJ, Raychaudhuri S, Reynolds R, Chin KA, Lee AY, Leveziel N, Zack DJ, Campochiaro P, Smith RT, Barile GR, Hogg RE, Chakravarthy U, Behrens TW, Uitterlinden AG, van Duijn CM, Vingerling JR, Brantley MA, Baird PN, Klaver CC, Allikmets R, Katsanis N, Graham RR, Ioannidis JP, Daly MJ, Seddon JM (2012) Ophthalmology 119(9): 1874-85
    › Primary publication · 22705344 (PubMed) · PMC3899891 (PubMed Central)
  9. Pharmacogenetics and age-related macular degeneration. Schwartz SG, Brantley MA (2011) J Ophthalmol : 252549
    › Primary publication · 22046503 (PubMed) · PMC3199209 (PubMed Central)
  10. Pattern electroretinography in age-related macular degeneration. Sheybani A, Brantley MA, Apte RS (2011) Arch Ophthalmol 129(5): 580-4
    › Primary publication · 21555610 (PubMed)